Santao Ou
Impact in
- Nephrology top 5%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- Parathyroid Disorders and Treatments
- Renal Diseases and Glomerulopathies
-
- Protease and Inhibitor Mechanisms
Papers in
- Nephrology 22
- Dialysis and Renal Disease Management 7
- Parathyroid Disorders and Treatments 6
- Renal Diseases and Glomerulopathies 5
- Chronic Kidney Disease and Diabetes 5
- Surgery 13
- Muscle and Compartmental Disorders 5
- Co-authors
- Weihua Wu (18 shared papers)Qi Liu (4 shared papers)Liling Zhang (8 shared papers)Zheng Jiang (2 shared papers)Li Li (1 shared paper)Ying Li (1 shared paper)Yue Chen (2 shared papers)Huipan Liu (1 shared paper)
- Journals
- Frontiers in Medicine (2 papers)Molecular Pharmaceutics (2 papers)Medicine (2 papers)Frontiers in Pharmacology (2 papers)Renal Failure (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Santao Ou
38 papers receiving 402 citations
Peers
Comparison fields: 5 of 76
- Nephrology 165
- Cancer Research 57
- Oncology 89
- Complementary and Manual Therapy 6
- Surgery 118
Countries citing papers authored by Santao Ou
This map shows the geographic impact of Santao Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santao Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santao Ou more than expected).
Fields of papers citing papers by Santao Ou
This network shows the impact of papers produced by Santao Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santao Ou. The network helps show where Santao Ou may publish in the future.
Co-authors
The 25 scholars most cited alongside Santao Ou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 105 | |
| 2 | 2021 | 79 | |
| 3 | 2022 | 25 | |
| 4 | 2018 | 21 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 16 | |
| 7 | [Aliskiren inhibits angiotensin II/angiotensin 1-7(Ang II/Ang1-7) signal pathway in rats with diabetic nephropathy]. | 2018 | 15 |
| 8 | 2021 | 15 | |
| 9 | 2019 | 12 | |
| 10 | 2017 | 10 | |
| 11 | Early protective role of MST1 knockdown in response to experimental diabetic nephropathy. | 2016 | 9 |
| 12 | 2024 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 6 | |
| 15 | Piwil 2 gene transfection changes the autophagy status in a rat model of diabetic nephropathy. | 2015 | 6 |
| 16 | 2023 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2024 | 3 |
About Santao Ou
Santao Ou is a scholar working on Nephrology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 47 papers that have together received 408 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (7 papers), Parathyroid Disorders and Treatments (6 papers), Renal Diseases and Glomerulopathies (5 papers), Muscle and Compartmental Disorders (5 papers), Chronic Kidney Disease and Diabetes (5 papers), Peptidase Inhibition and Analysis (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Thermoregulation and physiological responses (2 papers). The work is most often cited by research in Nephrology (165 citations), Cancer Research (57 citations), Oncology (89 citations), Complementary and Manual Therapy (6 citations) and Surgery (118 citations). Santao Ou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Weihua Wu, Qi Liu, Liling Zhang, Zheng Jiang, Li Li, Ying Li, Yue Chen, Huipan Liu, Jianhua Qin and Junzheng Wang. Their work appears in journals such as Frontiers in Medicine, Molecular Pharmaceutics, Medicine, Frontiers in Pharmacology and Renal Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.